Inside Back Cover: Discovery of Small-Molecule Inhibitors of the TLR1/TLR2 Complex (Angew. Chem. Int. Ed. 49/2012)

Authors

  • Dr. Kui Cheng,

    1. Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)
    Search for more papers by this author
  • Dr. Xiaohui Wang,

    1. Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)
    Search for more papers by this author
  • Shuting Zhang,

    1. Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)
    Search for more papers by this author
  • Prof. Dr. Hang Yin

    Corresponding author
    1. Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)
    • Department of Chemistry and Biochemistry and the BioFrontiers Institute, University of Colorado at Boulder, Boulder, CO 80309 (USA)
    Search for more papers by this author

Abstract

original image

Toll-like receptors (TLRs) play pivotal roles in innate immunity. Two key members of the TLR protein family, TLR1 (orange) and TLR2 (magenta), form a heterodimeric complex that recognizes pathogen-associated molecule patterns such as Pam3CSK4 (green) and activates inflammation response. On page 12246 ff., H. Yin and co-workers describe the new inhibitor CU-CPT22 (white), which displaces bound Pam3CSK4 from the TLR1–TLR2 complex, thus providing a valuable probe for these important signaling receptors.

Cartoon 1.

Ancillary